315 related articles for article (PubMed ID: 29757592)
1. The Profile of Toll-like Receptor 2 (TLR2), TLR4 and Their Cytosolic Downstream Signaling Pathway in Common Variable Immunodeficiency (CVID) Patients.
Sharifi L; Aghamohammadi A; Rezaei N; Yazdani R; Mahmoudi M; Amiri MM; Masoumi F; Bokaie S; Tavasolian P; Sanaei R; Moshiri M; Tavakolinia N; Alinia T; Azizi G; Mirshafiey A
Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):188-200. PubMed ID: 29757592
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1β and interleukin-6 in Common Variable Immunodeficiency and their association with subtypes of B cells and response to the Pneumovax-23 vaccine.
Sharifi L; Aghamohammadi A; Rezaei N; Yazdani R; Rezaei F; Bokaie S; Zavareh FT; Kiaee F; Kamali AN; Azizi G; Mirshafiey A
Eur Cytokine Netw; 2019 Dec; 30(4):123-129. PubMed ID: 32096473
[TBL] [Abstract][Full Text] [Related]
3. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency.
Lollo C; de Moraes Vasconcelos D; Oliveira LMDS; Domingues R; Carvalho GC; Duarte AJDS; Sato MN
Clin Immunol; 2016 Aug; 169():121-127. PubMed ID: 27392462
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic Property of G2013 (α-L-Guluronic Acid) on Gene Expression of MyD88, Tollip, and NF-κB in HEK293 TLR2 and HEK293 TLR4.
Sharifi L; Aghamohammadi A; Aletaha S; Bigdeli R; Asgary V; Bokaie S; Asgardoon MH; Azizi G; Mirshafiey A
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):144-149. PubMed ID: 30784390
[TBL] [Abstract][Full Text] [Related]
5. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.
Bulut Y; Faure E; Thomas L; Equils O; Arditi M
J Immunol; 2001 Jul; 167(2):987-94. PubMed ID: 11441107
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory Effect of G2013 (α-L-Guluronic Acid) on the TLR2 and TLR4 in Human Mononuclear Cells.
Sharifi L; Mohsenzadegan M; Aghamohammadi A; Rezaei N; Zavareh FT; Bokaie S; Moshiri M; Aghazadeh Z; Norouzbabaie Z; Azizi G; Mirshafiey A
Curr Drug Discov Technol; 2018; 15(2):123-131. PubMed ID: 28578651
[TBL] [Abstract][Full Text] [Related]
7. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.
de Lollo C; de Moraes Vasconcelos D; da Silva Oliveira LM; de Oliveira Titz T; Carneiro-Sampaio M; Jacob CM; da Silva Duarte AJ; Sato MN
J Transl Med; 2016 May; 14(1):138. PubMed ID: 27188997
[TBL] [Abstract][Full Text] [Related]
8. The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells.
Choi SY; Ryu HM; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Int Urol Nephrol; 2017 Jan; 49(1):171-181. PubMed ID: 27722989
[TBL] [Abstract][Full Text] [Related]
9. Human neonatal peripheral blood leukocytes demonstrate pathogen-specific coordinate expression of TLR2, TLR4/MD2, and MyD88 during bacterial infection in vivo.
Zhang JP; Yang Y; Levy O; Chen C
Pediatr Res; 2010 Dec; 68(6):479-83. PubMed ID: 20805788
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 7 and 9 defects in common variable immunodeficiency.
Yu JE; Knight AK; Radigan L; Marron TU; Zhang L; Sanchez-Ramón S; Cunningham-Rundles C
J Allergy Clin Immunol; 2009 Aug; 124(2):349-56, 356.e1-3. PubMed ID: 19592080
[TBL] [Abstract][Full Text] [Related]
11. The role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency.
Sharifi L; Mirshafiey A; Rezaei N; Azizi G; Magaji Hamid K; Amirzargar AA; Asgardoon MH; Aghamohammadi A
Expert Rev Clin Immunol; 2016; 12(2):195-207. PubMed ID: 26654573
[TBL] [Abstract][Full Text] [Related]
12. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
Vet Res; 2008; 39(2):11. PubMed ID: 18096120
[TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells.
Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Liu E; Peter K; Tipping P; Toh BH; Bobik A; Kyaw T
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27930350
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study.
Boileau J; Mouillot G; Gérard L; Carmagnat M; Rabian C; Oksenhendler E; Pasquali JL; Korganow AS;
J Autoimmun; 2011 Feb; 36(1):25-32. PubMed ID: 21075598
[TBL] [Abstract][Full Text] [Related]
15. Impaired pneumovax-23-induced monocyte-derived cytokine production in patients with common variable immunodeficiency.
Hong R; Agrawal S; Gollapudi S; Gupta S
J Clin Immunol; 2010 May; 30(3):435-41. PubMed ID: 20177958
[TBL] [Abstract][Full Text] [Related]
16. TLR-2, TLR-4 and MyD88 genes expression in renal transplant acute and chronic rejections.
Sharbafi MH; Assadiasl S; Pour-Reza-Gholi F; Barzegari S; Mohammadi Torbati P; Samavat S; Nicknam MH; Amirzargar A
Int J Immunogenet; 2019 Dec; 46(6):427-436. PubMed ID: 31286693
[TBL] [Abstract][Full Text] [Related]
17. Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (CVID).
Ganjalikhani-Hakemi M; Yazdani R; Esmaeili M; Abolhassani H; Rae W; Azizi G; Dizaji MZ; Shaghaghi M; Rezaei A; Abbasi-Rad F; Afshar-Qasemloo S; Mohammadi S; Rezaei N; Aghamohammadi A
Endocr Metab Immune Disord Drug Targets; 2017 Nov; 17(4):332-340. PubMed ID: 28925897
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the Interleukin-21 Pathway with Interleukin-4 Distinguishes Common Variable Immunodeficiency Patients with More Non-infectious Clinical Complications.
Desjardins M; Béland M; Dembele M; Lejtenyi D; Drolet JP; Lemire M; Tsoukas C; Ben-Shoshan M; Noya FJD; Alizadehfar R; McCusker CT; Mazer BD
J Clin Immunol; 2018 Jan; 38(1):45-55. PubMed ID: 29103189
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the TLR negative regulatory network in CVID patients.
Sanaei R; Rezaei N; Aghamohammadi A; Delbandi AA; Teimourian S; Yazdani R; Tavasolian P; Kiaee F; Tajik N
Genes Immun; 2019 Mar; 20(3):198-206. PubMed ID: 29618830
[TBL] [Abstract][Full Text] [Related]
20. Increased Expression of B Lymphocyte Induced Maturation Protein 1 (BLIMP1) in Patients with Common Variable Immunodeficiency (CVID).
Farrokhi S; Abbasi-Rad F; Esmaeil N; Sherkat R; Yazdani R; Afshar-Ghasemlou S; Fekrvand S; Ganjalikhani-Hakemi M
Iran J Allergy Asthma Immunol; 2020 Aug; 19(4):437-446. PubMed ID: 33463110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
